Engaged in diverse basic, translational and clinical research, our faculty routinely publish in prestigious journals and successfully compete for major grants from national funders.
NIH/NIAID (Morse) HIV/AIDS Clinical Trial Unit. Andrew Talal (Co-Principal Investigator). 12/1/2013-4/1/2028.
A Ribozyme Rescue Strategy for Dry Age-Related Macular Degeneration. John Sullivan (Principal Investigator). VA Central Office. $330,000. 1/1/2025-12/1/2027.
Exercise Reset for Concussion - Modifying the Buffalo Concussion Protocol for Application in a Military Environment. John Leddy (Principal Investigator). Department of Defense (CDMRP). 1/1/2023-12/1/2027.
Modulation of oligodendrocyte development by voltage-operated calcium channels. Pablo Paez (Principal Investigator). National Institute of Neurological Disorders and Stroke (NINDS). $1,993,750. 12/1/2021-11/1/2027.
Center for Advanced Technology in Big Data and Health Sciences. Norma Nowak (Principal Investigator). New York State Department of Empire State Development. $9,200,000. 7/1/2017-6/1/2027.
Molecular mechanisms of skin immunity to Staphylococcal infection. Lee Ann Garrett-Sinha (Co-Principal Investigator). NIH. $527,503. 7/1/2022-6/1/2027.
The role of the nociceptor endocytosis in inflammatory pain. Arin Bhattacharjee (Principal Investigator). National Institute of Neurological Disorders & Stroke. $1,907,471. 6/1/2022-5/1/2027.
T Regulatory cell responses in Toxoplasma-infected muscle. Elizabeth Wohlfert (Principal Investigator). NIAID/NIH. $2,445,371. 2/1/2022-3/1/2027.
A Multicenter Randomized Controlled Trial of Best Available Therapy versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis, BEAT-MS (Protocol ITN077AI). Bianca Weinstock-Guttman (Principal Investigator). National Institute of Allergy & Infectious Diseases (NIAID), Division of Allergy, Immunology &Transplantation (DAIT) via a subaward. 1/1/2020-12/1/2026.
Impacts of Nicotinamide Riboside on functional capacity and muscle physiology in older veterans. Nikhil Satchidanand (Co-Investigator). Veterans Affairs. 1/1/2022-12/1/2026.
Immunomodulatory Therapy After Resuscitation From Cardiac Arrest. Olga Pletnikova (Consultant). NIH. 1/1/2022-12/1/2026.
MARCH proteins, members of a host protein family that targets HIV. Spyridon Stavrou (Principal Investigator). NIH/NIAID. $1,974,920. 12/1/2021-11/1/2026.
Effects of mesolimbic amylin signaling on macronutrient intake. Jinwoo Park (Co-Investigator). NIH/NIDDK. $2,202,189. 12/1/2021-11/1/2026.
Tonawanda Coke Environmental Health Study. Laurene Tumiel Berhalter (Co-Investigator). US District Court for the Western District of New York. $11,100. 9/1/2016-9/1/2026.
The Tonawanda Health Study: An Epidemiologic Study of Health Effects and Coke Oven Emissions from Tonawanda Coke. James Olson (Co-Investigator). US Attorney’s Office, Department of Justice, Tonawanda Coke Corp. $7,933,256. 9/1/2016-9/1/2026.